newsfilter
← Latest News
GlobeNewswire·

Vivos Therapeutics Announces Pricing of $21M Initial Public Offering

HIGHLANDS RANCH, Colo., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos”), a medical technology company that offers novel and proprietary alternatives for treating...